n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide has been researched along with Nerve Degeneration in 1 studies
N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide: thrombin inhibitor; RN given refers to parent cpd without isomeric designation
Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedmann, I | 1 |
| Yoles, E | 1 |
| Schwartz, M | 1 |
1 other study available for n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide and Nerve Degeneration
| Article | Year |
|---|---|
Thrombin attenuation is neuroprotective in the injured rat optic nerve.
Topics: Administration, Topical; Animals; Antithrombins; Dipeptides; Nerve Crush; Nerve Degeneration; Neurop | 2001 |